The National Cancer Institute (NCI), through its Cancer Treatment Research program (CFDA 93.395), awarded a $603,206 project grant to Ne Scientific LLC on May 1, 2024. The grant supports the evaluation of a software system developed by Ne Scientific that provides computer-guided support to physicians performing percutaneous microwave ablation procedures to treat liver tumors. The software simulates the physics of the ablation process and highlights on CT images the tissues that have been successfully treated, enabling physicians to better assess complete tumor coverage and reduce the rate of incomplete ablations. The 3-year clinical trial will monitor tumor recurrence rates in 84 patients who undergo the microwave ablation procedure with the computerized guidance system. If successful, this technology could provide a minimally invasive cancer treatment option without the side effects of chemotherapy or radiotherapy.
Generated 2/25/25, 2:42 AM